Treatment and prognosis of pseudomyxoma peritonei
Abstract：Objective To summarize the experience of treating pseudomyxoma peritonei (PMP) and analyzed the prognosis. Methods A total of 42 patients with pseudomyxoma peritonei (PMP) treated in our hospital from 1990-2008were analyzed retrospectively. OF the 42 patients, 21 underwent cytoreductive surgery(CRS group),19 underwent CRS and intraoperative peritoneal hyperthermia-chemotherapy(CRS + IPHC group).The median follow-up period was 6.8years(range, 1～16 years). Results There was no significant difference in 1-year survival rate hetween the CRS group and CRS + IPHC group (P>0.05).The 3,5-year survival rates were significant higher in CRS + IPHC group than in CRS group, while the recurrence rate was in contrast (P<0.05). Conclusions The using of CRS and IPHC might improve the survival rate of patients with PMP.
Keywords：pseudomyxoma peritoneicytoreductionintraoperative peritoneal hyperthermia-chemotherapy
Publication Date：2010-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 57-58,62 )